Evaluation of Predisposing Metabolic Risk Factors for Portopulmonary Hypertension in Patients with NASH Cirrhosis

References

• Hervé P, Lebrec D, Brenot F, et al. Pulmonary vascular disorders in portal hypertension. Eur Respir J. 1998;11:1153–1166. doi:10.1183/09031936.98.11051153
   PubMed Web of Science ®Google Scholar
• Steckelberg RC, Tseng AS, Nishimura R, et al. Derivation of mean pulmonary artery pressure from noninvasive parameters. J Am Soc Echocardiogr. 2013;26:464–468. doi:10.1016/j.echo.2013.01.006
   PubMed Web of Science ®Google Scholar
• Fisher MR, Forfia PR, Chamera E, et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med. 2009;179:615–621. doi:10.1164/rccm.200811-1691OC
   PubMed Web of Science ®Google Scholar
• Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2014;63:746–753.
   Google Scholar
• Chabot F, Gomez E, Boyer L, et al. Porto-pulmonary hypertension. Rev Mal Respir. 2006;23:629–641. doi:10.1016/S0761-8425(06)72078-2
   PubMed Web of Science ®Google Scholar
• Pilatis ND, Jacobs LE, Rerkpattanapipat P, et al. Clinical predictors of pulmonary hypertension in patients undergoing liver transplant evaluation. Liver Transplant off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. 2000;6:85–91.
   Google Scholar
• Krowka MJ, Swanson KL, Frantz RP, McGoon MD, Wiesner RH. Portopulmonary hypertension: results from a 10-year screening algorithm. Hepatol Baltim Md. 2006;44(6):1502–1510. doi:10.1002/hep.21431
   PubMed Web of Science ®Google Scholar
• Puchakayala BK, Verma S, Kanwar P, et al. Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease. World J Hepatol. 2015;7:2610–2618. doi:10.4254/wjh.v7.i25.2610
   PubMed Web of Science ®Google Scholar
• Sanyal AJ, Chalasani N. Trials and tribulations in drug development for nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol. 2014;12:2104–2105. doi:10.1016/j.cgh.2014.08.005
   PubMed Web of Science ®Google Scholar
• Eshraghian A, Hamidian Jahromi A. Non-alcoholic fatty liver disease and thyroid dysfunction: a systematic review. World J Gastroenterol. 2014;20(25):8102–8109. doi:10.3748/wjg.v20.i25.8102
   PubMed Web of Science ®Google Scholar
• Amarapurkar D, Kamani P, Patel N, et al. Prevalence of non-alcoholic fatty liver disease: population based study. Ann Hepatol. 2007;6(3):161–163. doi:10.1016/S1665-2681(19)31922-2
   PubMed Web of Science ®Google Scholar
• Li J, Zhuang O, Zhang X, et al.Prevalence and prognosis of portopulmonary hypertension in 223 liver transplant recipients. Can Respir J. 2018;2018:9629570. doi:10.1155/2018/9629570
   PubMed Web of Science ®Google Scholar
• Reymond M, Barbier L, Salame E, et al. Does portopulmonary hypertension impede liver transplantation in cirrhotic patients? A French multicentric retrospective study. Transplantation. 2018;102:616–622. doi:10.1097/TP.0000000000001981
   PubMed Web of Science ®Google Scholar
• Krowka MJ, Miller DP, Barst RJ, et al. Portopulmonary hypertension: a report from the US-based REVEAL registry. Chest. 2012;141:906–915.
   PubMed Web of Science ®Google Scholar
• Liberal R, Grant CR, Baptista R, et al. Porto-pulmonary hypertension: a comprehensive review. Clin Res Hepatol Gastroenterol. 2015;39(2):157–167.
   PubMed Web of Science ®Google Scholar
• Colle IO, Moreau R, Godinho E, et al. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study. Hepatology. 2003;37:401–409. doi:10.1053/jhep.2003.50060
   PubMed Web of Science ®Google Scholar
• Raevens S, Colle I, Reyntjens K, et al. Echocardiography for the detection of portopulmonary hypertension in liver transplant candidates: an analysis of cutoff values. Liver Transpl. 2013;19:602–610. doi:10.1002/lt.23649
   PubMed Web of Science ®Google Scholar
• Malik R, Hodgson H. The relationship between the thyroid gland and the liver. Q J Med. 2002;95:559–569. doi:10.1093/qjmed/95.9.559
   Google Scholar
• Saleem WM, Wadea FM. Evaluation of thyroid dysfunction in Egyptian chronic hepatitis c virus cirrhotic patients complicated with portal hypertension. Int J Sci Res. 2016;5:595–600.
   Google Scholar
• El-Sawy AA, Tawfi KM. Low serum free and total tri-iodothyronine hormones as possible prognostic factors in liver cirrhotic patients because of chronic hepatitis C. Tanta Med J. 2015;43:46–51. doi:10.4103/1110-1415.158048
   Google Scholar
• El-Feki MA, Abdalla NH, Atta MI, et al. Serum level of thyroid hormones in patients with chronic hepatitis C virus infection. Open J Endocr Metab Dis. 2016;6:126–134. doi:10.4236/ojemd.2016.63017
   Google Scholar
• Antonelli A, Ferri C, Fallahi P, et al. Thyroid Involvement in patients with overt HCV-related mixed cryoglobulinaemia. QJM Int J Med. 2004;97(8):499–506. doi:10.1093/qjmed/hch088
   PubMed Web of Science ®Google Scholar
• D’costa L, Dhume CY. Assessment of thyroid parameters in alcoholic liver disease. Int J Pharm Biosci. 2016;7:771–776.
   Google Scholar
• Kayacetin E, Kisakol G, Kaya A. Low serum total thyroxine and free triiodothyronine in patients with hepatic encephalopathy due to non-alcoholic cirrhosis. Swiss Med Wkly. 2003;133:210–213.
   PubMed Web of Science ®Google Scholar
• Spencer CA, Takeuchi M, Kazarosyan M. Current status and performance goals for serum thyrotropin (TSH) assays. Clin Chem. 1996;42:140–145. doi:10.1093/clinchem/42.1.140
   PubMed Web of Science ®Google Scholar
• Vargas-Uricoechea H, Bonelo-Perdomo A, Sierra-Torres CH. Effects of thyroid hormones on the heart. Clin Investig Arterioscler. 2014;26:296–309. doi:10.1016/j.arteri.2014.07.003
   PubMedGoogle Scholar
• Mohr-Kahaly S, Kahaly G, Meyer J. Cardiovascular effects of thyroid hormones. Z Kardiol. 1996;85:219–231.
   PubMedGoogle Scholar
• Duntas LH, Mantzou E, Koutras DA. Circulating levels of oxidized low-density lipoprotein in overt and mild hypothyroidism. Thyroid. 2002;12:1003–1007. doi:10.1089/105072502320908349
   PubMed Web of Science ®Google Scholar
• Ittermann T, Baumeister SE, Völzke H, et al. Are serum TSH levels associated with oxidized low-density lipoprotein? Results from the Study of Health in Pomerania. Clin Endocrinol (Oxf). 2012;76:526–532. doi:10.1111/j.1365-2265.2011.04186.x
   PubMed Web of Science ®Google Scholar
• Siemińska L, Wojciechowska C, Walczak K, et al. Associations between metabolic syndrome, serum thyrotropin, and thyroid antibodies status in postmenopausal women, and the role of interleukin-6. Endokrynol Pol. 2015;66:394–403. doi:10.5603/EP.2015.0049
   PubMed Web of Science ®Google Scholar
• Tvarijonaviciute A, Jaillardon L, Cerón JJ, Siliart B. Effects of thyroxin therapy on different analytes related to obesity and inflammation in dogs with hypothyroidism. Vet J. 2013;196:71–75. doi:10.1016/j.tvjl.2012.08.005
   PubMed Web of Science ®Google Scholar